As Associate Director of the EGRP for the National Cancer Institute’s Division of Cancer Control and Population Sciences, Erin established scientific and strategic priorities for EGRP, the largest funder of cancer epidemiologic research worldwide. The DCCPS plays a unique role in reducing the burden of cancer in America as NCI’s bridge to public health research, practice, and policy. Prior to joining NCI in June 2024, Erin was a Senior Member in the Departments of Cancer Epidemiology and Gastrointestinal Oncology at the Moffitt Cancer Center and Research Institute where she has 20 years’ experience building and leveraging patient cohorts and biorepositories to advance high-impact team science. In addition, she was instrumental in leading and providing strategic direction of Moffitt’s institutional biobanking protocol: the Total Cancer Care Protocol (TCC) over 10 years and served as PI since 2021.
Alliance for Rare Cancers I Jedi Rare Cancer Foundation
P.O. Box 683501, Park City, Utah 84068
The Alliance for Rare Cancers is a fiscally sponsored program of the Jedi Rare Cancer Foundation, a 501(c)(3) nonprofit organization, accepting tax-deductible donations from individuals, corporations, family-advised funds, and foundations. Federal Tax ID 86-2610819. All donations are tax deductible as allowed by law.
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.